Northrop Grumman (NYSE:NOC) will be issuing its quarterly earnings data before the market opens on Wednesday, July 24th. Analysts expect the company to announce earnings of $4.64 per share for the quarter. Northrop Grumman has set its FY19 guidance at $18.90-19.30 EPS.Parties that are interested in registering for the company’s conference call can do so using this link.
Northrop Grumman (NYSE:NOC) last posted its quarterly earnings results on Wednesday, April 24th. The aerospace company reported $5.06 earnings per share for the quarter, beating the consensus estimate of $4.59 by $0.47. Northrop Grumman had a return on equity of 41.42% and a net margin of 9.67%. The firm had revenue of $8.19 billion for the quarter, compared to analyst estimates of $8.34 billion. During the same period in the previous year, the firm earned $4.21 earnings per share. Northrop Grumman’s quarterly revenue was up 21.6% on a year-over-year basis. On average, analysts expect Northrop Grumman to post $19 EPS for the current fiscal year and $22 EPS for the next fiscal year.
Shares of NOC stock opened at $323.20 on Tuesday. The company has a debt-to-equity ratio of 1.59, a quick ratio of 1.10 and a current ratio of 1.18. The firm has a market cap of $54.70 billion, a price-to-earnings ratio of 15.15, a P/E/G ratio of 1.29 and a beta of 0.80. The business has a 50-day moving average price of $319.09. Northrop Grumman has a fifty-two week low of $223.63 and a fifty-two week high of $330.26.
A number of analysts have commented on NOC shares. UBS Group raised their price objective on Willis Towers Watson from $202.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Susquehanna Bancshares upgraded Northrop Grumman from a “neutral” rating to a “positive” rating and raised their target price for the stock from $309.00 to $315.00 in a research report on Friday, April 5th. Morgan Stanley set a $18.00 target price on PG&E and gave the stock a “hold” rating in a research report on Friday, June 14th. Barclays restated a “buy” rating on shares of Netflix in a research report on Thursday, May 16th. Finally, ValuEngine upgraded Zynerba Pharmaceuticals from a “hold” rating to a “buy” rating in a research report on Friday, May 17th. Six analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $338.24.
Northrop Grumman Company Profile
Northrop Grumman Corporation, a security company, provides products in the areas of autonomous systems, cyber, space, strikes, and logistics and modernizations in the United States, the Asia Pacific, and internationally. The company operates through four segments: Aerospace Systems, Innovation Systems, Mission Systems, and Technology Services.
Further Reading: Federal Reserve
Receive News & Ratings for Northrop Grumman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northrop Grumman and related companies with MarketBeat.com's FREE daily email newsletter.